TY  - JOUR
AU  - Laurent, Pierre-Antoine
AU  - André, Fabrice
AU  - Bobard, Alexandre
AU  - Deandreis, Desiree
AU  - Demaria, Sandra
AU  - Depil, Stephane
AU  - Eichmüller, Stefan
AU  - Fernandez-Palomo, Cristian
AU  - Foijer, Floris
AU  - Galluzzi, Lorenzo
AU  - Galon, Jérôme
AU  - Guckenberger, Matthias
AU  - Harrington, Kevin J
AU  - Herrera, Fernanda G
AU  - Huber, Peter
AU  - Italiano, Antoine
AU  - Karam, Sana D
AU  - Kroemer, Guido
AU  - Lambin, Philippe
AU  - Leuschner, Carola
AU  - Mantovani, Alberto
AU  - Meylan, Etienne
AU  - Mondini, Michele
AU  - Pittet, Mikael J
AU  - Pouget, Jean-Pierre
AU  - Remon, Jordi
AU  - Sørensen, Claus S
AU  - Sotiriou, Christos
AU  - Vanpouille-Box, Claire
AU  - Weichselbaum, Ralph R
AU  - Welsh, James W
AU  - Zitvogel, Laurence
AU  - Formenti, Silvia C
AU  - Deutsch, Eric
TI  - Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference.
JO  - OncoImmunology
VL  - 14
IS  - 1
SN  - 2162-4011
CY  - Abingdon
PB  - Taylor & Franics
M1  - DKFZ-2024-02756
SP  - 2432726
PY  - 2025
AB  - Over the last decade, the annual Immunorad Conference, held under the joint auspicies of Gustave Roussy (Villejuif, France) and the Weill Cornell Medical College (New-York, USA) has aimed at exploring the latest advancements in the fields of tumor immunology and radiotherapy-immunotherapy combinations for the treatment of cancer. Gathering medical oncologists, radiation oncologists, physicians and researchers with esteemed expertise in these fields, the Immunorad Conference bridges the gap between preclinical outcomes and clinical opportunities. Thus, it paves a promising way toward optimizing radiotherapy-immunotherapy combinations and, from a broader perspective, improving therapeutic strategies for patients with cancer. Herein, we report on the topics developed by key-opinion leaders during the 7th Immunorad Conference held in Paris-Les Cordeliers (France) from September 27th to 29th 2023, and set the stage for the 8th edition of Immunorad which will be held at Weill Cornell Medical College (New-York, USA) in October 2024.
KW  - Humans
KW  - Neoplasms: immunology
KW  - Neoplasms: radiotherapy
KW  - Neoplasms: therapy
KW  - Immunotherapy: methods
KW  - Combined Modality Therapy
KW  - Radiotherapy: methods
KW  - Cancer (Other)
KW  - FLASH radiotherapy (Other)
KW  - T cells (Other)
KW  - immune checkpoint (Other)
KW  - immunorad (Other)
KW  - immunotherapy (Other)
KW  - low-dose radiotherapy (Other)
KW  - lymph-node sparing (Other)
KW  - radiotherapy (Other)
KW  - tumor-associated macrophages (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:39696783
C2  - pmc:PMC11660406
DO  - DOI:10.1080/2162402X.2024.2432726
UR  - https://inrepo02.dkfz.de/record/296013
ER  -